Literature DB >> 35353262

Translation, internal consistency, reliability and validity of the Thai version of Gout Assessment Questionnaire version 2.0 (GAQ 2.0).

Nathrudee Phrintrakul1,2, Antika Wongthanee3, Nuntana Kasitanon1, Worawit Louthrenoo4.   

Abstract

OBJECTIVES: To translate the Gout Assessment Questionnaire version 2.0 (GAQ2.0) with Gout Impact (GI) Scale (GIS) into Thai and determine its psychometric property in gout patients with acute arthritis (acute arthritis group) and during the intercritical period (chronic gout group).
METHODS: Translation followed the ISPOR recommendations. Cronbach's α, intraclass correlation coefficient (ICC) and standardized response mean (SRM) were used to determine internal consistency, reliability and responsiveness to change, respectively. Correlations between GI subscales with generic health-related quality of life (HRQoL) questionnaires (SF-36, HAQ-DI and EQ-5D-5L) and gout clinical parameters were determined.
RESULTS: The acute arthritis group and the chronic gout group comprised 27 and 92 patients, respectively. Internal consistency was sufficient for all GI subscales (Cronbach's α = 0.80-0.98), reliability was moderate to good in most GI subscales (ICC = 0.54-0.88) and responsiveness to change was moderate to large in most GI subscales (SRM = 0.43-0.98). The GI subscales correlated better with SF-36 than HAQ-DI and EQ-5D-5L. In the acute arthritis group, the unmet gout treatment needs subscale showed large and moderate negative correlation with tophi and serum uric acid, respectively. In the chronic gout group, the gout concern overall subscale had statistically significant, moderate correlation with overall gout severity rated by the patients and number of gout attacks over the past year, while the well-being during attack subscale and total GIS score had statistically significant, moderate correlation with overall gout severity rated by the patients.
CONCLUSION: The Thai GAQ2.0 GIS showed acceptable internal consistency, reliability and responsiveness to change and correlated significantly with generic HRQoL questionnaires and clinical parameters. Key Points • The Thai GAQ2.0 GIS showed acceptable internal consistency, reliability and responsiveness to change in gout patients both during acute attack and during the intercritical period • The GI subscales showed significant correlation with SF-36 and HAQ questionnaires and gout clinical parameters in gout patients both during acute attack and during the intercritical period • The Thai GAQ2.0 GIS subscales should be used in conjunction with generic HRQoL for complete HRQoL assessment in gout patients.
© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Gout; HRQoL; Health-related quality of life; Patient outcomes assessment

Mesh:

Substances:

Year:  2022        PMID: 35353262     DOI: 10.1007/s10067-022-06148-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

1.  Predictors of doctor-rated and patient-rated gout severity: gout impact scales improve assessment.

Authors:  Andrew J Sarkin; Ashley E Levack; Marian M Shieh; Arthur F Kavanaugh; Dinesh Khanna; Jasvinder A Singh; Robert A Terkeltaub; Susan J Lee; Jan D Hirsch
Journal:  J Eval Clin Pract       Date:  2010-08-15       Impact factor: 2.431

2.  Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans.

Authors:  J A Singh; V Strand
Journal:  Ann Rheum Dis       Date:  2008-01-04       Impact factor: 19.103

Review 3.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

Review 4.  Gout.

Authors:  Nicola Dalbeth; Anna L Gosling; Angelo Gaffo; Abhishek Abhishek
Journal:  Lancet       Date:  2021-03-30       Impact factor: 79.321

5.  Patients with Gout Treated with Conventional Urate-lowering Therapy: Association with Disease Control, Health-related Quality of Life, and Work Productivity.

Authors:  Robert Wood; Steve Fermer; Sulabha Ramachandran; Scott Baumgartner; Robert Morlock
Journal:  J Rheumatol       Date:  2016-04-01       Impact factor: 4.666

6.  Quality of life and disability in patients with treatment-failure gout.

Authors:  Michael A Becker; H Ralph Schumacher; Katy L Benjamin; Peter Gorevic; Maria Greenwald; Jeffrey Fessel; Lawrence Edwards; Ariane K Kawata; Lori Frank; Royce Waltrip; Allan Maroli; Bill Huang; John S Sundy
Journal:  J Rheumatol       Date:  2009-03-30       Impact factor: 4.666

Review 7.  Gout and mortality.

Authors:  S Y Kim; M A De Vera; H K Choi
Journal:  Clin Exp Rheumatol       Date:  2008 Sep-Oct       Impact factor: 4.473

8.  Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. Community Oriented Programme for the Control of Rheumatic Disease.

Authors:  P Chaiamnuay; J Darmawan; K D Muirden; P Assawatanabodee
Journal:  J Rheumatol       Date:  1998-07       Impact factor: 4.666

9.  Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey.

Authors:  Puja P Khanna; George Nuki; Thomas Bardin; Anne-Kathrin Tausche; Anna Forsythe; Amir Goren; Jeffrey Vietri; Dinesh Khanna
Journal:  Health Qual Life Outcomes       Date:  2012-09-22       Impact factor: 3.186

10.  Familial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in Taiwan.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Lai-Chu See; Kuang-Hui Yu; Shue-Fen Luo; Ana M Valdes; Weiya Zhang; Michael Doherty
Journal:  Ann Rheum Dis       Date:  2013-11-21       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.